Sustainability of medical devices is emerging as a new pillar of European industrial strategy.
But in healthcare, one question is central: how can we ensure that the pursuit of sustainability does not compromise the safety or clinical performance of medical devices?
With the European Green Deal and the upcoming Ecodesign for Sustainable Products Regulation (ESPR), sustainable medical devices have become a top priority.
This shift directly affects product design, certification, and the clinical evaluation of medical devices.
Toward a greener European framework for the sustainability of medical devices
The European Green Deal and the proposed Ecodesign Regulation for Sustainable Products encourage manufacturers to integrate sustainability throughout the entire product lifecycle.
The goal: reduce waste, promote reuse, lower carbon footprint, and improve environmental traceability.
MedTech Europe emphasizes that “sustainability and health are two inseparable dimensions of the same ambition — a responsible and resilient healthcare system” (medtecheurope.org).
For medical devices, this means new requirements: material selection, reparability, logistics, product lifespan, and end-of-life management.
Yet this technical transformation brings a critical challenge — maintaining clinical validation and patient safety.
The direct link between sustainability of medical devices and clinical evaluation
The clinical evaluation of medical devices, as defined by Regulation (EU) 2017/745 (MDR), aims to demonstrate safety, performance, and clinical benefit.
However, sustainability strategies can influence these parameters at multiple levels.
1. More sustainable materials require new clinical validation
Switching to recycled plastics, bio-based composites, or reusable metals can alter biocompatibility and device behavior.
Such changes require a new clinical evaluation — even if the intended function remains the same — to confirm tolerance, stability, and long-term safety.
2. Reuse and re-sterilization: a major clinical challenge
An increasing number of devices are designed to be reusable or reprocessed.
Each use cycle may affect performance, sterility, or accuracy.
Manufacturers must demonstrate, through testing or usability studies, that sustainability does not degrade clinical performance or safety.
Example: a reusable stainless-steel surgical instrument or a rechargeable physiological sensor must prove consistent performance after several use cycles.
3. Long-term performance and extended clinical follow-up
Sustainable medical devices are designed for longer lifespans.
This requires extended post-market clinical follow-up (PMCF) to monitor clinical performance over years of use.
The PMCF Plan, required under MDR Annex XIV, should include durability indicators such as wear, maintenance, material fatigue, or functional drift.
4. Environmental impact as complementary data
Although current clinical regulations do not mandate environmental metrics, several authorities — including France’s HAS — now encourage including environmental value in market access or reimbursement dossiers, particularly for single-use devices (has-sante.fr).
Sustainability of medical devices and clinical acceptability: finding the right balance
The drive toward sustainability of medical devices must not create a trade-off between ecological responsibility and clinical benefit.
Regulators now require dual alignment:
- Regulatory compliance with MDR safety and performance requirements, and
- Environmental and clinical coherence with European sustainability goals.
According to KPMG (2023), manufacturers that integrate sustainability early in product design gain competitiveness:
“Circular and repairable devices show higher acceptance rates among healthcare institutions.” (kpmg.com)
Integrating sustainability into clinical strategy
Anticipating the clinical implications of sustainability helps avoid late non-compliance.
Regulatory experts recommend:
- Integrating sustainability objectives directly into the clinical evaluation plan,
- Validating new materials and processes through biocompatibility and usability studies,
- Planning post-market follow-up with durability-related performance indicators,
- Engaging clinical and R&D teams in ecological design discussions.
Thus, the clinical evaluation of medical devices becomes a tool of coherence — not only proving efficacy but also ensuring durable and responsible clinical performance.
Toward convergence between clinical evidence and environmental sustainability
The sustainability of medical devices marks a new era in healthcare — one of responsible innovation that combines patient safety, clinical efficiency, and reduced environmental impact.
The challenge for manufacturers is clear:
to make sustainability not a constraint, but a core clinical value and a differentiating factor in market access and brand trust.
Useful links
- MedTech Europe – Environmental and Social Sustainability
- KPMG – Sustainability in the Medical Device Industry
- Intertek – Life Cycle Assessments in Medical Devices
- Green Deal Observatory – Sustainable Medical Devices
- See article on the same subject: Sustainable development of medical devices: an unavoidable challenge for healthcare systems
